The D9N, N291S and S447X variants in the lipoprotein lipase (LPL) gene are not associated with Type III Hyperlipidemia

BMC Medical Genetics

Volumn 8, Issue , 2007, Pages

  Evans, David ^a   Beil, Frank U ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E2; LIPOPROTEIN LIPASE;

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; HUMAN; HYPERLIPIDEMIA; MAJOR CLINICAL STUDY; MALE; RISK ASSESSMENT; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; ALLELE; GENETICS; HYPERLIPOPROTEINEMIA TYPE 3; MIDDLE AGED;

ADULT; ALLELES; APOLIPOPROTEIN E2; FEMALE; GENOTYPE; HUMANS; HYPERLIPOPROTEINEMIA TYPE III; LIPOPROTEIN LIPASE; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 35348888266     PISSN: None     EISSN: 14712350     Source Type: Journal    
DOI: 10.1186/1471-2350-8-56     Document Type: Article

References (15)

1. Mahley RW Huang Y Rall SC Pathogenesis of type III hyperlipoproteinemia (dysbetalipoproteinemia): Questions, quandaries and paradoxes J Lipid Res 1999, 40:1933-1949. 10552997
2. Mahley RW Rall SC Type III Hyperlipoproteinemia (Dysbetalipoproteinemia): The role of apolipoprotein E in normal and abnormal lipoprotein metabolism The Metabolic and molecular bases of inherited disease McGraw Hill. New York Scriver et al 8 2001:2835-2862
3. Evans D Seedorf U Beil FU Polymorphisms in the apolipoprotein A5 (APOA5) gene and type III hyperlipidemia Clin Genet 2005, 68:369-372. 10.1111/ j.1399-0004.2005.00510.x 16143024
4. Zhang H Reymer PWA Liu MS Forsythe IJ Groenemeyer BE Frohlich J Brunzell JD Kastelein JJP Hayden MR Ma Y Patients with ApoE3 deficiency (E2/2, E3/ 2, and E4/2) who manifest with hyperlipidemia have an increased frequency of an Asn 291 → Ser mutation in the human LPL gene Arterioscler Thromb Vasc Biol 1995, 15:1695-1703. 7583546
5. Sijbrands EJG Hoffer MJV Meinders AE Havekes LM Frants RR Smelt AHM De Knijff P Severe hyperlipidemia in apolipoprotein E2 homozygotes due to a combined effect of hyperinsulinemia and an SstI polymorphism Arterioscler Thromb Vasc Biol 1999, 19:2722-2729. 10559017
6. Schaap FG Rensen PCN Voshol PJ Vrins C van der Vliet HN Chamuleau RAFM Havekes LM Groen AK van Dijk KW ApoAV reduces plasma triglycerides by inhibiting very low density lipoprotein-triglyceride (VLDL-TG) production and stimulating lipoprotein lipase-mediated VLDL-TG hydrolysis J Biol Chem 2004, 279:27941-27947. 10.1074/jbc.M403240200 15090553
7. Mailly F Tugrul Y Reymer PWA Bruin T Seed M Groenemeyer BF Asplund-Carlson A Vallance D Winder AF Miller GJ Kastelein JJP Hamsten A Olivecrona G Humphries SE Talmud P A common variant in the gene for lipoprotein lipase (Asp9→Asn): Functional implications and prevalence in normal and hyperlipidemic subjects Arterioscler Thromb Vasc Biol 1995, 15:468-78. 7749858
8. Busca R Peinado J Vilella E Auwerx J Deeb S Vilaro S Reina M The mutant Asn291ser human lipoprotein lipase is associated with reduced catalytic activity and does not influence binding to heparin FEBS Lett 1995, 367:257262. 10.1016/0014-5793(95)00582-T
9. Wittrup HH Tybjaerg-Hansen A Nordestgaard BG Lipoprotein lipase mutations, plasma lipids and lipoproteins, and risk of ischemic heart disease: A meta-analysis Circulation 1999, 99(22):2901-2907. 10359734
10. Brümmer D Evans D Berg D Greten H Beisiegel U Mann WA Expression of Type III hyperlipoproteinemia in patients homozygous for apolipoprotein E-2 is modulated by lipoprotein lipase and postprandial hyperinsulinemia J Mol Med 1998, 76:355-364. 10.1007/s001090050227 9587070
11. Evans D Buchwald A Beil FU The single nucleotide polymorphism -1131T > C in the apolipoprotein A5 (APOA5) gene is associated with elevated triglycerides in patients with hyperlipidemia J Mol Med 2003, 81:645-654. 10.1007/s00109-003-0465-4 12937897
12. Marks D Thorogood M Neil HAW Humphries SE A review on the diagnosis, natural history, and treatment of familial hypercholesterolemia Atherosclerosis 2003, 168:1-14. 10.1016/S0021-9150(02)00330-1 12732381
13. Blom DJ O'Neill FH Marais AD Screening for Dysbetalipoproteinemia by Plasma Cholesterol and Apolipoprotein B Concentrations Clin Chem 2005, 51:904-907. 10.1373/clinchem.2004.047001 15855667
14. Hixson JE Vernier DT Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with Hha I J Lipid Res 1990, 31:545-8. 2341813
15. Cohen JC Kiss RS Pertsemlidis A Marcel YL McPherson R Hobbs HH Multiple rare alleles contribute to low plasma levels of HDL Science 2004, 305:869-872. 10.1126/science.1099870 15297675